Source:http://linkedlifedata.com/resource/pubmed/id/20871666
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2010-9-27
|
pubmed:abstractText |
Drosophila models of tauopathies have been developed by transgenically overexpressing the disease-associated forms of tau. In this paper we report for the first time that a recently developed Grape-Seed Polyphenolic Extract (GSPE) improves the eye phenotype of a Drosophila eye model of R406W tau. GSPE-mediated improvements in this distinct in vivo neurodegeneration model for protein misfolding/aggregation suggest that GSPE may have therapeutic value in disorders involving aberrant protein aggregation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:status |
PubMed-not-MEDLINE
|
pubmed:issn |
2090-0252
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
2010
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:year |
2010
|
pubmed:articleTitle |
Grape-seed polyphenolic extract improves the eye phenotype in a Drosophila model of tauopathy.
|
pubmed:affiliation |
Department of Oncological Sciences, Mount Sinai School of Medicine, One Gustave L. Levy Place, NY 10029, USA.
|
pubmed:publicationType |
Journal Article
|